GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » Net Change in Cash

FDC (NSE:FDC) Net Change in Cash : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is FDC Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

FDC's Net Change in Cash for the three months ended in Mar. 2024 was ₹0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

FDC Net Change in Cash Historical Data

The historical data trend for FDC's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FDC Net Change in Cash Chart

FDC Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.61 5.55 72.94 -138.39 15.34

FDC Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FDC Net Change in Cash Calculation

FDC's Net Change in Cash for the fiscal year that ended in Mar. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=2207.674+-170.832+-2021.572+0.067
=15

FDC's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=0+0+0+0
=0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FDC Net Change in Cash Related Terms

Thank you for viewing the detailed overview of FDC's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

FDC (NSE:FDC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » Net Change in Cash
Comparable Companies
BOM:530019 BOM:524558 NSE:STAR BOM:532872 BOM:524348 BOM:543322 BOM:524742 BOM:532482 BOM:543748 BOM:500126 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
531599:India
Address
C-3 Skyvistas, Near Versova Police Station, D.N. Nagar, Andheri (West), Mumbai, MH, IND, 400053
Website
https://www.fdcindia.com
FDC Ltd is an Indian-based pharmaceutical company with USFDA and UK-MHRA-approved API and formulations manufacturing facilities. It has its presence in numerous therapeutic segments: Anti-infectives, Gastro-Intestinal, Vitamins/Minerals/Nutrients, Ophthalmology/Otologicals, Cardiac, Dermatology, Respiratory, Gynaecology, and Others. The company's brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The majority of the revenue is generated domestically.

FDC (NSE:FDC) Headlines

From GuruFocus

Leon Cooperman's Top 5 Holdings

By James Li James Li • 06-20-2019

Consolidated Research: 2019 Summary Expectations for First Data, IDEXX Laboratories, CMS Energy, Worthington Industries, Triumph Group, and Cara Therapeutics — Fundamental Analysis, Key Performance Indications

By Marketwired Marketwired • 01-24-2019

Leon Cooperman on Surviving Fame and Infamy

By Robert Abbott Robert Abbott • 01-31-2018

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of First Data Corporation to Fiserv is Fair to Shareholders

By Marketwired Marketwired • 01-24-2019

Steve Mandel Starts 3 New Positions in 3rd Quarter

By Sydnee Gatewood Sydnee Gatewood • 11-29-2018

Systum Partners with CardConnect to Deliver a Seamless and Secure Customer Experience

By Marketwired Marketwired • 06-28-2018

Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of First Data, TCF Financial, and Versum Materials on Behalf of Stockholders and Encourages Investors to Contact the Firm

By Marketwired Marketwired • 02-10-2019

FIRST DATA CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger

By Marketwired Marketwired • 01-24-2019

Consolidated Research: 2019 Summary Expectations for First Data, Ellington Financial, Oasis Midstream Partners LP, Allena Pharmaceuticals, Winmark, and PICO — Fundamental Analysis, Key Performance Indications

By Marketwired Marketwired • 04-11-2019

Revention Partners with First Data to Offer Integrated Payment Processing

By PRNewswire PRNewswire • 06-05-2018